Su Ir Lyu

9PUBLICATIONS
51CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 12, 2026
Sex-Specific Proteomic Profiling Identifies Pregnancy Zone Protein as a Complement-Linked Marker of Adverse Prognosis in Esophageal Adenocarcinoma.

|Dec 19, 2025
Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.

Felix John, Lea Ruge, Malte Verheyen

|Nov 27, 2025
Loss of Argininosuccinate Synthetase-1 (ASS1) Occurs in Esophageal Adenocarcinoma and Represents a Promising Biomarker for Therapy with Pegargiminase.

Karl Knipper, Su Ir Lyu, Eleni Tzitzili

|Aug 21, 2025
Expression patterns of TROP2 and Nectin-4 in oropharyngeal squamous cell carcinoma in relation to HPV status: potential biomarkers for targeted therapy.

Charlotte Klasen, Hans N C Eckel, Nora Wuerdemann

|Jul 11, 2025
Local T-Cell Dysregulation and Immune Checkpoint Expression in Human Papillomavirus-Mediated Recurrent Respiratory Papillomatosis.

Hans N C Eckel, Su Ir Lyu, Frederik Faste

|Jun 26, 2025
Impact of Surgical Margin Distance on Oncologic Outcomes in Vulvar Squamous Cell Carcinoma.

Caroline Lenz, Su Ir Lyu, Peter Mallmann

Pageof 2

Frequent Collaborators

5 joint publications

Alexander Quaas

2 joint publications

Karl Knipper

2 joint publications

Thomas Schmidt

2 joint publications

Marcel Mayer